SCHEMBL351597

SCHEMBL351597

CNC1CCS(=O)(=O)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2055574 1.00
SCHEMBL2055572 1.00
Hydrochloric Acid SCHEMBL11200377 0.98 ALDH1A1 (0.61)
SCHEMBL14644747 0.86 ALDH1A1 (0.44)
SCHEMBL765701 0.84 ALDH1A1 (0.45)
Hydrochloric Acid SCHEMBL15549019 0.82 ALDH1A1 (0.48)
SCHEMBL8979299 0.81 ALDH1A1 (0.53)
SCHEMBL15002032 0.78
SCHEMBL11591431 0.75
SCHEMBL713379 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 216 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140294704-A1 SOLVENT AND METHOD FOR REMOVAL OF AN ACID GAS FROM A FLUID STREAM THE UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 2014-10-02 US claimed
EP-0059356-B1 SUBSTITUTED 3-AMINO-SYDNONIMINE, PROCESS FOR THEIR PREPARATION AND THEIR APPLICATION CASSELLA Aktiengesellschaft (DE) 1985-05-02 EP claimed
CN-122055805-A Super capacitor comprising sulfur-based electrolyte system 京瓷AVX元器件公司 2026-05-15 CN disclosed
US-12595243-B2 Modulators of extracellular signal-regulated kinase GEN1E LIFESCIENCES INC. (US) 2026-04-07 US disclosed
US-20260042764-A1 COMPOSITIONS AND METHODS FOR INHIBITION OF KRAS THERAS INC (US) 2026-02-12 US disclosed
US-20250285817-A1 Ultracapacitor for Use in a Solder Reflow Process KYOCERA AVX Components Corporation 2025-09-11 US disclosed
US-20250136571-A1 MODULATORS OF EXTRACELLULAR SIGNAL-REGULATED KINASE GEN1E LIFESCIENCES INC. 2025-05-01 US disclosed
US-20250132104-A1 Ultracapacitor Including a Sulfur-Based Electrolyte System KYOCERA AVX Components Corporation 2025-04-24 US disclosed
WO-2025085753-A1 ULTRACAPACITOR INCLUDING A SULFUR-BASED ELECTROLYTE SYSTEM KYOCERA AVX Components Corporation (US) 2025-04-24 WO disclosed
US-11992494-B2 Cyclopentathiophene carboxamide derivatives as platelet activating factor receptor antagonists BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2024-05-28 US disclosed
WO-2024019995-A1 QUINOXALINEDIONE AND PYRIDO [2, 3-B]PYRAZINE-2, 3-DIONE B CELL LYMPHOMA 6 (BCL6) DEGRADERS AND USES THEREOF DANA-FARBER CANCER INSTITUTE, INC. (US) 2024-01-25 WO disclosed
US-20060100236-A1 For therapy of disorder of reduced motility of gastrointestinal tract, chronic constipation, functional dyspepsia, delayed gastric emptying, gastroesophageal reflux disease, gastroparesis, diabetic and iodiopathic gastropathy, post-operative ileus, intestinal pseudo-obstruction, irritable bowel syndrome THERAVANCE, INC. (US) 2006-05-11 US disclosed
US-20050197335-A1 1-isopropyl-1H-indazole-3-carboxylic acid {(1S,3R,5R)-8-[2-(4-acetylpiperazin-1-yl)-ethyl]8-azabicyclo[3.2.1]oct-3-yl}amide; improved pharmacokinetic, bioavailability; gastrointestinal disorders: irritable bowel syndrome (IBS), chronic constipation, dyspepsia; CNS behavioral, mood disorder THERAVANCE BIOPHARMA R&D IP, LLC 2005-09-08 US disclosed
WO-2005080389-A1 INDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS THERAVANCE, INC. (US) 2005-09-01 WO disclosed
US-20040029898-A1 Substituted quinolines as antitumor agents ASTRAZENECA AB (SE) 2004-02-12 US disclosed
US-5326760-A Aminobutanoic acid compounds having metalloprotease inhibiting properties GLAXO, INC. (US) 1994-07-05 US disclosed
WO-1994000119-A1 AMINOBUTANOIC ACID COMPOUNDS HAVING METALLOPROTEASE INHIBITING PROPERTIES GLAXO INC. (US) 1994-01-06 WO disclosed
US-4374040-A ANTICORROSION, ANTISCALE, ANTIDERPOSIT BUCKMAN LABORATORIES, INC. (US) 1983-02-15 US disclosed
US-4243524-A ANTISCALING, ANTISLUDGING BUCKMAN LABORATORIES, INC. (US) 1981-01-06 US disclosed
US-4181806-A ANTISLUDGING AGENTS, ANTISCALING AGENTS BUCKMAN LABORATORIES, INC. (US) 1980-01-01 US disclosed